ArticleFrontiers in immunology2026
PLA2G2A is a candidate biomarker for sepsis diagnosis in mice through machine learning algorithms.
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: In this study, machine-learning screening was implemented on human transcriptomic data from public GEO datasets and independent experiments were served to validate candidate biomarkers for sepsis in mice models. Methods: Microarray data were obtained from the GSE236713 dataset, and differentially expressed genes (DEGs) were screened. We carried out enrichment analysis with the help of gene ontology (GO) and Kyoto encyclopedia of genes and genomes (KEGG). We utilized machine learning algorithms, such as least absolute shrinkage and selection operator (LASSO), logistic regression (LR), support vector machine (SVM). For the key genes, we conducted single-gene enrichment and immune Infiltration Analysis. We selected C57BL/6J SPF-grade male mice to construct a sepsis model. The proteins were then detected via western blotting (WB), tissue homogenization, tissue staining, immunohistochemistry (IHC), and cytokines. Results: Multiple groups of DEGs were identified via dataset analysis. Weighted gene co-expression network analysis (WGCNA) was used to identify related modules. Machine learning was used to screen key genes, such as cholinergic receptor muscarinic 1 (CHRM1) and Secreted phospholipase A2 (sPLA2-IIA) (encoded by Conclusion: In this study, we identified PLA2G2A as the candidate biomarker for diagnosis of sepsis in mice models through machine learning algorithms. And the data obtained may be helpful for subsequent research on sepsis pathogenesis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.